LBA47 Primary analysis of phase II results for cemiplimab in patients (pts) with locally advanced basal cell carcinoma (laBCC) who progress on or are intolerant to hedgehog inhibitors (HHIs)Alexander Stratigos, M.G. Fury, Aleksandar Sekulić et al.|Annals of Oncology|2020Cited by 14
Setting trends with google: limits and perspectives when utilising search engine dataS Springer, Michael Zieger, Martin Kaatz et al.|Quality & Quantity|2025Cited by 2